Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control (International Journal of Experimental Pathology 90 (156-165) DOI: 10.1111/j.1365-2613.2008.00624.x);Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control

International Journal of Experimental Pathology

Volumn 90, Issue 2, 2009, Pages 156-165

  Quitete, Valéria Helena Alves Cagnon ^a   Fávaro, Wagner José ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Diabetes mellitus; Dystroglycan; Immunohistochemistry; Insulin; Ventral prostate

Indexed keywords

ALPHA DYSTROGLYCAN; ALPHA DYSTROGLYCAN RECEPTOR; BETA DYSTROGLYCAN; BETA DYSTROGLYCAN RECEPTOR; GLUCOSE; ISOPHANE INSULIN; RECEPTOR; SODIUM CHLORIDE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BASEMENT MEMBRANE; CELL ADHESION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; INSULIN TREATMENT; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE DISEASE; PROSTATE EPITHELIUM; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

EID: 62749135961     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00672.x     Document Type: Erratum

References (77)

1. Ader M., Richey J.M., Bergman R.N. (1998) Evidence for direct action of alloxan to induce insulin resistance at the cellular level. Diabetologia 41, 1327 1336.
2. Anderson L.C. (1983) Effects of alloxan diabetes and insulin in vivo on rat parotid gland. Am. J. Physiol. 245, 431 437.
3. Aumüller G. Ader G. (1979) Experimental studies of apocrine secretion in the dorsal prostate ephitelium of the rat. Cell Tissue Res. 198, 145 158.
4. Aumüller G. Seitz J. (1990) Protein secretion and secretory processes in male accessory sex gland. Int. Rev. Citol. 121, 127 231.
5. Ballester J., Munoz M.C., Dominguez J., Rigau T., Guinovart J.J., Rodriguez-Gil J.E. (2004) Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J. Androl. 25, 706 719.
6. Basaria S., Muller D.C., Carducci M.A., Egan J., Dobs A.S. (2006) Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106, 581 588.
7. Behmer O.A., Tolosa E.M.C., Freitas-Neto A.G. (1976) Manual Para Histologia Normal e Patológica. São Paulo : Edart-Edusp, P. 225.
8. Brennan P., Jing J., Ethunandan M., Gorecki D. (2004) Dystroglycan complex in cancer. Eur. J. Surg. Oncol. 30, 589 592.
9. Buck A.C., Reed P.I., Siddiq Y.K., Chisholm G.P., Russel E.T. (1976) Bladder dysfunction and neuropathy in diabetes. Diabetologia 12, 251.
10. Cagnon V.H.A., Camargo A.M., Rosa R.M., Fabiani C.R., Padovani C.R., Martinez F.E. (2000) Ultra structure study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57bl/6j). Tissue Cell 32, 275 283.
11. Caldeira E.J. Cagnon V.H.A. (2007) IGF-I and INS receptor expression in the salivary glands of diabetic Nod mice submitted to long-term insulin treatment. Cell Biol. Int. 32, 16 21.
12. Carvalho C.A.F., Camargo A.M., Cagnon V.H.A., Padovani C.R. (2003) Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6j and NOD mice. Anat. Rec. 270, 129 136.
13. Ciardullo A.V., Daghio M.M., Brunnetti M. et al. (2004) Audit of shared-care program for persons with diabetes: baselina na 3 annual follow-ups. Acta Diabetol. 41, 9 13.
14. Colombel M.C. Buttyan R. (1995) Hormonal control of apoptosis: the rat prostate gland prostate as a model system. Methods Cell Biol. 46, 369 385.
15. Conget I. (2002) Diagnosis, classification and pathogenesis of diabetes mellitus. Rev. Esp. Cardiol. 55, 528 538.
16. Cornell R.J., Rowley D., Wheller T., Ali N., Ayala G. (2003) Neuroepithelial interactions in prostate cancer are enhanced in the presence of prostatic stroma. Urology 61, 870 875.
17. Costello C.L. Franklin B.R. (1994) Effects of prolactin on the prostate. Prostate 24, 162 166.
18. Cunha G.R. Matrisian L.M. (2002) It's not my fault, blame it on my microenvironment. Differentiation 70, 469 472.
19. Cunha G.R., Risbridger G., Wang H., Young P. (2001) Evidence that epithelial mesenchymal estrogen receptor-α mediates effects of estrogen on prostatic epithelium. Dev. Biol. 229, 432 442.
20. Cunha G.R., Hayward S.W., Wang Y.Z. (2002) Role of stroma in carcinogenesis of the prostate. Differentiation 70, 473 485.
21. Cunha G.R., Hayward S.W., Wang Y.Z., Ricke W.A. (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 107, 1 10.
22. Daubrese J.C., Meunier J., Wilmotte A.S., Luyckx A.S., Lefebvre P.J. (1978) Pituitary-testicular axisin diabetic men with and without impotence sexual. Diabete Metab. 4, 233 237.
23. Ekman P. (2000) The prostate as an endocrine organ: androgens and estrogens. Prostate 10, 14 18.
24. Ellemberg M. (1980) Sexual function in diabetic patients. Ann. Intern. Med. 92, 331 333.
25. Frenkel G.P., Homonnal Z.P., Drasmin N., Sofer A., Kaplan R., Kraicer P.F. (1978) Fertility of the streptozotocin-diabetic male rat. Andrologia 10, 127 136.
26. Hammarsten J. Hogstedt B. (2002) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur. Urol. 39, 151 158.
27. Henry M.D. Campbell K.P. (1998) A role for dystroglycan in basement membrane assembly. Cell 95, 859 870.
28. Henry M.D., Cohen M.B., Campbell K.P. (2001) Reduced expression of dystroglycan in breast an prostate cancer. Hum. Pathol. 32, 791 795.
29. Ho S.M. (1991) Prostatic androgen receptor and plasma testosterone levels in streptozotocin-induced diabetic rats. J. Steroid Biochem. Mol. Biol. 38, 67 72.
30. Hood J.D. Cheresh D.A. (2002) Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91 100.
31. Hu Y., Nakagawa Y., Purushotham K.R., Humphreys-Beher M.G. (1992) Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263, 607 614.
32. Humprhreys-Beher M.G., Yamachika S., Yamamoto H. et al. (1998) Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger? Eur. J. Morphol. 36, 247 251.
33. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696 702.
34. Ilic M., Vlajinac H., Marinkovic J. (1996) Case-control study of risk factors for prostate cancer. Br. J. Cancer 74, 1682 1686.
35. Jackson F.L. Hutson J.C. (1984) Altered responses to androgens in diabetic male rats. Diabetes 33, 819.
36. Jesik C.J., Holland J.M., Lee C. (1982) An anatomic and histologic study of the rat prostate. Prostate 3, 81 97.
37. Kasper J.S., Liu Y., Pollak M.N., Rifai N., Giovannucci E. (2008) Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control. 19, 703 710.
38. Knox J.D., Cress A.E., Clark V. et al. (1994) Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am. J. Pathol. 145, 167 174.
39. Kreis T. Vale R. (1999) Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. New York, NY : Oxford University Press.
40. Leav I., Lau K.M., Adams J.A. et al. (2001) Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159, 79 92.
41. Lin C.Q. Bissel M.J. (1993) Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB 7, 737 743.
42. Losasso C., Di Tommaso F., Sgambato A. et al. (2000) Anomalous dystroglycan in carcinoma cell lines. FEBS Lett. 484, 194 198.
43. Lyons A.J. Jones J. (2007) Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int. J. Oral Maxillofac. Surg. 36, 671 679.
44. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. (1980) Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29, 1 13.
45. Marker P.C., Donjacour A.A., Dahiya R., Cunha G.R. (2003) Hormonal cellular and molecular control of prostatic development. Dev. Biol. 253, 165 174.
46. Markopoulos A.K., Poulopoulos A.K., Kavavis I., Papanayotou P. (2000) Immunohistochemical detection on insulin-like growth factor I in the labial salivary glands of patients with Sjogren's syndrome. Oral Dis. 6, 31 34.
47. Martin R.M., Silva A., Lew A.M. (1997) The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype. Immunogenetics 46, 167 168.
48. Mcculloch D.K., Young R.J., Prescott R.J., Campbell I.W., Clarke B.F. (1984) The natural history of impotence in diabetic men. Diabetologia 26, 437 440.
49. Mokdad A.H. (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286, 1195.
50. Ohta T., Matsui K., Miyajima K. et al. (2007) Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats. Exp. Anim. 56, 355 362.
51. Oksanen A. (1975) Testicular lesion of streptozotocin diabetic rats. Horm. Res. 6, 138 144.
52. Pierce B.L., Plymate S., Ostrander E.A., Stanford J.L. (2008) Diabetes mellitus and prostate cancer risk. Prostate 68, 1126 1132.
53. Raz A. (2004) Dystroglycan: to adhere or not adhere during cancer progression. Cancer Biol. Ther. 3, 967 975.
54. Ribeiro D.L., Caldeira E.J., Candido E.M., Manzato A.J., Taboga S.R., Cagnon V.H. (2006) Prostatic stromal microenvironment and experimental diabetes. Eur. J. Histochem. 50, 51 60.
55. Saito M., Nishi K., Foster-Junior H.E., Weiss R.M., Latifpour J. (1996) Effect of experimental diabetes on rat prostate endothelin receptors. Eur. J. Pharm. 310, 197 200.
56. Setchell B.P., Brooks P.E. (1988) Anatomy, vasculature. Innervation, and fluids of the male reproductive tract. In : The Physiology of Reproduction, pp. 753 836 (eds E. Knobil, J. Neill New York, NY : Raven Press.
57. Sgambato A. Brancaccio A. (2005) The dystroglycan complex: from biology to cancer. J. Cell. Physiol. 205, 163 169.
58. Sgambato A., Migaldi M., Montanari M. et al. (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 162, 849 860.
59. Sgambato A., Camerini A., Amoroso D. et al. (2007) Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma. Cancer Biol. Ther. 6, 1840 1846.
60. Shirai H., Sato T., Hara T., Minagi S. (1998) The effect of diabetes mellitus on histopathological changes in the tissues under denture base and without mechanical pressure. J. Oral Rehabil. 5, 715 720.
61. Soudamani S., Yuvaraj S., Malini T., Balasubramanian K. (2005) Experimental diabetes has adverse effects on the differentiation of ventral prostate during sexual maturation of rats. Anat. Rec. 287, 1281 1289.
62. Stefan S.F. (1996) Definition and classification of diabetes including maturity-onset diabetes of the young. In : Diabetes Mellitus: A Fundamental and Clinical, pp. 251 295 (ed Stefan SF W.B. Saunders : Philidelphia.
63. Sufrin G. Scott W.W. (1972) Effect of drug-induced diabetes on response accessory sex organs of castrate rats to testosterone proprionate. Urol. Surg. 23, 534 535.
64. Sugimura Y., Cunha G.R., Donjacour A.A. (1986) Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. Biol. Reprod. 34, 973 983.
65. Sugita S., Saito F., Tang J., Satz J., Campbell K., Südhof T.C. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 23, 435 445.
66. Suthagar E., Soudamani S., Yuvaraj S., Ismail Khan A., Aruldhas M.M., Balasubramanian K. (2008) Effects of streptozotocin (STZ)-induced diabetes and insulin replacement on rat ventral prostate. Biomed. Pharmacother (Epub ahead of print).
67. Tesone M., Valle L.B.S., Foglia V.G., Charreau E.H. (1976) Endocrine function of the testis in streptozotocin diabetic rats. Acta Physiol. Lat. 26, 387 394.
68. Tesone M., Oliveira-Filho R.M., Valle L.B. et al. (1980) Androgen receptors in the diabetic rat. Diabetologia 18, 385 390.
69. Tuxhorn J.A., Ayala G.E., Rowley D.R. (2001) Reactive stroma in prostate cancer progression. J. Urol. 166, 2472 2483.
70. Untergasser G., Madersbacher S., Berger P. (2005) Benign prostatic hyperplasia: age-related tissue-remodeling. Exp. Gerontol. 40, 121 128.
71. Wang Z.J., Ikeda K., Foster H.E., Weiss R.M., Latifpour J. (2000) Expression and localization of basic fibroblast growth factor in diabetic rat prostate. BJU Int. 85, 945 952.
72. Weir M.L., Oppizzi M.L., Henry M.D. et al. (2006) Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. J. Cell Sci. 119, 4047 4058.
73. Will J.C., Vinicor F., Calle E.E. (1999) Is diabetes mellitus associated with prostate incidence and survival? Epidemiology 10, 313 318.
74. Winder S.J. (2001) The complexities of dystroglycan. TIBS 26, 118 124.
75. Wong Y.C., Xie W., Tsao S.W. (2000) Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats. Prostate 45, 289 298.
76. Yamano S., Atkinson J.C., Baum B.J., Fox P.C. (1999) Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin. Immunol. 92, 265 275.
77. Zar J.H. (1999) Biostatistical Analysis. New Jersey : Prentice Hall, pp. 663.